| NAGASAKI UNIVERSITY Patent applications |
| Patent application number | Title | Published |
|---|
| 20130060015 | METHOD FOR PRODUCING GLUCOSIDES - The present invention relates to methods for producing glucosides directly from glucose or a polysaccharide comprising glucose as a structural unit. The present invention provides a method comprising reacting glucose or a polysaccharide comprising glucose as a structural unit with a compound represented by R—OH in the presence of a supercritical or subcritical carbon dioxide to produce glucosides and a method comprising dissolving or suspending glucose or a polysaccharide comprising glucose as a structural unit in an organic solvent containing a compound represent by R—OH and reacting the glucose or polysaccharide with the compound represented by R—OH in the presence of a supercritical or subcritical carbon dioxide to produce glucosides. | 03-07-2013 |
| 20130052678 | URACIL-SPECIFIC FLUORESCENCE DETECTION REACTION AND METHOD FOR EXAMINING DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY - The invention provides a method of detecting uracil. The method comprises reacting uracil with a compound represented by the formula (I) in the presence of an oxidant and a base to produce a fluorescent compound represented by the formula (II). | 02-28-2013 |
| 20130052127 | COMPOSITE BODY FOR ANTIGEN OR DRUG DELIVERY - The invention provides an antigen or drug delivery complex containing a complex of an antigen or drug and a cationic molecule, and an anionic molecule encapsulating the same. The antigen or drug delivery complex can be used as a main component of a drug delivery system that delivers various antigens and drugs to a particular cell or organ. | 02-28-2013 |
| 20120183972 | DNA CAPABLE OF INDUCING OSTEOBLAST-SPECIFIC EXPRESSION, AND NUCLEOTIDE SEQUENCE FOR SAME - The invention provides nucleotide sequences that function as enhancers and induce osteoblast-specific expression, expression vectors comprising such an enhancer, a promoter, and a gene containing a coding region, as well as screening methods utilizing such expression vectors. | 07-19-2012 |
| 20120165259 | AGENT FOR AMELIORATING BLOOD-BRAIN BARRIER DISORDERS - The invention provides a method of ameliorating a blood-brain barrier disorder, as well as a method of treating a disease accompanied by a blood-brain barrier disorder and a method of treating a cerebral ischemic disease, by administering a prothymosin α, or a protein or polypeptide possessing the same function as the prothymosin α. The invention also provides polypeptides useful in the context of the aforesaid methods. | 06-28-2012 |
| 20120161551 | RELUCTANCE MOTOR - A reluctance motor according to an aspect of an embodiment includes a stator and a mover. One of the stator and the mover includes a plurality of magnetic poles on which coils are wound. The other of the stator and the mover includes a magnetic segment that includes a directivity member of which the magnetization direction is regulated in a predetermined direction and that is embedded into a non-magnetic holder. | 06-28-2012 |
| 20120100422 | COMPOSITE NANO POROUS ELECTRODE MATERIAL, PROCESS FOR PRODUCTION THEREOF, AND LITHIUM ION SECONDARY BATTERY - This invention provides a nano composite porous electrode material that has high charge-discharge behavior and charge or discharge capacity and a manufacturing method thereof. It also provides a lithium-ion secondary battery using this nano composite porous electrode material. | 04-26-2012 |
| 20120094173 | MACRO-POROUS GRAPHITE ELECTRODE MATERIAL, PROCESS FOR PRODUCTION THEREOF, AND LITHIUM ION SECONDARY BATTERY - This invention provides a macroporous graphite electrode material that may be manufactured at a low temperature of 1500° C. or less and may be fast charged and discharged and a manufacturing method thereof. It also provides a lithium-ion secondary battery using this macroporous graphite electrode material. | 04-19-2012 |
| 20110182917 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR GENERALIZED PAIN SYNDROME - Provided is a therapeutic or prophylactic agent for generalized pain syndrome, for which no cause and therapies have been established. A therapeutic or prophylactic agent for generalized pain syndrome containing an LPA1 antagonist or autotaxin-inhibiting substance as an active ingredient. The pharmaceutical is preferably administered to the central nervous system. The generalized pain syndrome is preferably fibromyalgia, chronic fatigue syndrome or hypersensitivity colitis. | 07-28-2011 |
| 20110046509 | METHOD OF MEASURING ELECTRICAL RESISTANCE VALUE OF CORNEAL TRANS-EPITHELIUM - The invention provides a method for evaluating a corneal disorder quantitatively and is applicable to living eyes. In particular, the invention provides a method for measuring a corneal transepithelial electric resistance, which method comprises: (1) a step of placing a first electrode on the cornea and a second electrode on the conjunctiva; and (2) a step of flowing an electric current between the first electrode and the second electrode to measure the electric resistance. The invention also provides a device for measuring a corneal transepithelial electric resistance value. | 02-24-2011 |
| 20100277956 | CONTROL APPARATUS OF POWER CONVERTER CIRCUIT - To detect a peak time of an exciting current of a transformer, a primary current corresponding to the peak time, or a variation time of the primary voltage, and to switch a switch after expiration of a predetermined period from the peak time, after the peak time occurs. A control apparatus | 11-04-2010 |
| 20100264839 | LOAD CONTROL DEVICE, AND LIGHTING DEVICE - Provided is a discharge lamp lighting device, which can control a load precisely while improving the practicability. When the difference of a count number (Nn) becomes a predetermined threshold value or less, a predictor circuit ( | 10-21-2010 |
| 20100209923 | Probe for diagnosis of marfan syndrome and a method for screening using the probe - The purpose of this invention is to provide a probe for diagnosis of Marfan syndrome, which enables early diagnosis of Marfan syndrome, and to provide a method for screening using said probe. The invention is a probe for a Marfan Syndrome characterized by using a nucleic acid comprising following (a) or (b);
| 08-19-2010 |
| 20100105918 | METAL COMPLEX, LIGHT-EMITTING DEVICE AND DISPLAY - A novel luminescent metal complex comprises a composition of [(Pt | 04-29-2010 |
| 20100010231 | METAL COMPLEX, LUMINESCENT DEVICE AND DISPLAY APPARATUS - There is provided a novel luminescent metal complex. A metal complex having a composition of [(Pt | 01-14-2010 |
| 20100003191 | AURONE DERIVATIVE-CONTAINING COMPOSITION FOR DIAGNOSIS - The present invention provides a composition for diagnosing amyloid-related diseases, comprising a compound represented by general formula (I): | 01-07-2010 |
| 20090320658 | Cutting Methods and Cutting Apparatus - The present invention provides cutting methods and cutting apparatus that can precisely cut workpieces in complicated shapes with high aspect ratios regardless of materials of the workpieces. The present invention is cutting methods and cutting apparatus using a wire saw wherein cutting processing is performed for a workpiece by extending a cutting wire on a cutting arm that rotates around a wire's center axis or a real cutting position relative to a fixed section and rotating the cutting arm such that a cutting direction of the wire matches a support direction of a total stiffness that supports the wire. | 12-31-2009 |
| 20090047305 | METHOD OF PRODUCING PROANTHOCYANIDIN OLIGOMER - The present invention relates to a composition containing as its main component proanthocyanidin oligomer to which a substance having a phloroglucinol ring structure or resorcinol ring structure has been bonded, and reduced in the molecular weight, which is obtained by heating plant materials containing proanthocyanidin polymer or extract thereof with a substance having a phloroglucinol ring structure or resorcinol ring structure in an acidic aqueous solution, production method thereof, and uses of the composition in health products and pharmaceutical products. According to the invention, proanthocyanidin oligomer having physiological activity, to which a substance having a phloroglucinol ring structure or resorcinol ring structure has been bonded and reduced in the molecular weight to such a level that the oligomer can be absorbed into living body, which has been conventionally difficult to obtain at high yield from plant raw materials, can be produced efficiently and easily. | 02-19-2009 |
| 20080199856 | Probe for Diagnosis of Marfan Syndrome and a Method for Screening Using the Probe - The purpose of this invention is to provide a probe for diagnosis of Marfan syndrome, which enables early diagnosis of Marfan syndrome, and to provide a method for screening using said probe. The invention is a probe for a Marfan Syndrome characterized by using a nucleic acid comprising following (a) or (b);
| 08-21-2008 |
